Study | Treatment | Animal ID | Gender | Age | Starting weight |
---|---|---|---|---|---|
1 |
Group I (placebo) | 95020 | M | 14.8 | 10.2 |
R05029 | M | 4.9 | 6.1 | ||
R05053 | M | 4.8 | 7.8 | ||
R05058 | M | 4.8 | 7.3 | ||
R05073 | M | 4.8 | 6.6 | ||
Group II (Roactemra) | 95031 | M | 14.8 | 12.7 | |
BB226 | M | 6.8 | 9.9 | ||
R04042 | M | 5.9 | 7.5 | ||
R05059 | M | 4.8 | 6.9 | ||
R05061 | M | 4.8 | 7.2 | ||
R05089 | F | 4.8 | 5.1 | ||
R05090 | M | 4.7 | 8.0 | ||
2 |
Group III (placebo) | R00062 | F | 12.2 | 5.2 |
R02049 | F | 10.3 | 7.7 | ||
R05068 | F | 7.3 | 5.9 | ||
R06045 | M | 6.3 | 7.2 | ||
R07111 | M | 5.2 | 5.6 | ||
Group IV (abatacept) | 96089 | F | 16.3 | 8.5 | |
R01091 | F | 11.1 | 5.0 | ||
R05084 | F | 7.3 | 6.9 | ||
R07003 | M | 5.5 | 6.5 | ||
R07031 | F | 5.4 | 4.6 | ||
R07068 | M | 5.3 | 7.6 | ||
R07075 | F | 5.3 | 5.2 |